- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04767087
Honey and Nigella Sativa in COVID-19 Prophylaxis (HNS-COVID-PK)
July 1, 2021 updated by: Sohaib Ashraf
Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial
Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles.
So it is planned to test for its prophylaxis
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
1000
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sohaib Ashraf, MBBS
- Phone Number: 8573167995
- Email: sohaib@skzmdc.edu.pk
Study Contact Backup
- Name: Ahmad Imran, MBBS
- Phone Number: +923338110708
- Email: ahmad.imran@skzmdc.edu.pk
Study Locations
-
-
MA
-
Lahore, MA, Pakistan, 54600
- Recruiting
- Shaikh Zayed Post-Graduate Medical Institute
-
Contact:
- Ahmad Imran, MBBS
- Phone Number: +923338110708
- Email: ahmad.imran@skzmdc.edu.pk
-
Contact:
- Sohaib Ashraf, MBBS
- Phone Number: 03334474523
- Email: sohaib@skzmdc.edu.pk
-
Principal Investigator:
- Iqra Farooq, MBBS
-
Principal Investigator:
- Larab Kalsoom, MBBS
-
Sub-Investigator:
- Shahroze Arshad, MBBS
-
Sub-Investigator:
- Maaz Akram, MBBS
-
Principal Investigator:
- Uzma N Siddique, MBBS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Health care professionals Post-exposure COVID-19
Exclusion Criteria:
- Multi-organ failure active COVID-19
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Honey and Nigella sativa Arm
0.5 g/kg/day honey 40 mg/Kg/day Nigella sativa seeds
|
0.5 gm/Kg/day honey
40 mg/Kg/day
|
Placebo Comparator: Placebo Arm
empty capsule with sugar water
|
empty capsule with sugar water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SARS-CoV-2 infection rate
Time Frame: 14 days
|
RT-PCR SARS-CoV-2
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sohaib Ashraf, MBBS, Massachusetts General Hospital
- Study Chair: Muhammad Ashraf, PhD, University of Veterinary and Animal Sciences
- Principal Investigator: Ahmad Imran, MBBS, Shaikh Zayed Post-Graduate Medical Institute
- Principal Investigator: Moneeb Ashraf, MBBS, King Edward Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 5, 2021
Primary Completion (Anticipated)
February 15, 2022
Study Completion (Anticipated)
April 15, 2022
Study Registration Dates
First Submitted
February 20, 2021
First Submitted That Met QC Criteria
February 20, 2021
First Posted (Actual)
February 23, 2021
Study Record Updates
Last Update Posted (Actual)
July 2, 2021
Last Update Submitted That Met QC Criteria
July 1, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SZMC/IRB/Internal/273/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Ricardo Pereira MestreInstitute of Oncology Research (IOR); Istituto Cantonale di PatologiaCompleted
-
Livzon Pharmaceutical Group Inc.Simoon Record Pharma Information Consulting Co., Ltd.; Guangdong Center for...Completed
-
Instituto de Investigación Hospital Universitario...Instituto de Salud Carlos III; Spanish Clinical Research Network - SCReNActive, not recruiting
-
Inmunova S.A.Hospital Italiano de Buenos Aires; Laboratorio Elea Phoenix S.A.; Hospital de... and other collaboratorsCompleted
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompleted
-
Rush University Medical CenterHospital Civil de GuadalajaraCompletedCovid19United States, Mexico
-
Evelyne D.TrottierCompleted
-
Sinovac Research and Development Co., Ltd.Completed
Clinical Trials on Honey
-
Postgraduate Medical Institute, LahoreCompleted
-
Ain Shams UniversityCompleted
-
Celal Bayar UniversityRecruiting
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece
-
Providence University, TaiwanUnknown
-
Universiti Sains MalaysiaRecruitingDiabetes Mellitus | Diabetes | Wound Heal | HoneyMalaysia
-
Waiariki Institute of TechnologyManuka Health New ZealandCompleted
-
All India Institute of Medical Sciences, New DelhiPostgraduate Institute of Medical Education and Research; Jawaharlal Institute...CompletedPressure Ulcer | Critically Ill Children | Pressure Sore | Bed SoreIndia
-
mamdouh abdulmaksoud abdulrhmanCompletedIdiopathic Dilated Cardiomyopathy
-
Ain Shams UniversityCompletedAcute Lymphoblastic LeukemiaEgypt